The Effect of Patient Discharge From the Maternal and Fetal Medicine Unit With Receiving a Discharge Letter Later Using the Apollo App on Discharge Data, Safety and Patient Satisfaction
1 other identifier
interventional
140
1 country
1
Brief Summary
Women admitted to the maternal and fetal medicine unit are often discharged after a short hospital stay. The routine work in the department is prioritized such that the discharge letter are written. In the last year the Apollo mobile application (app) was introduced. It contains general information on the medical center and the maternal and fetal unit department as well as the medical records, laboratory results and summary and discharge letters. The Apollo app is used in the maternal and fetal unit in the discharge process so the patient can receive the discharge letter in the app and does not need to wait until the discharge letter is written. It is not known whether this process is more effective than the regular discharge process and patients' satisfaction was not assessed previously. In the present study we will compare discharge data, satisfaction and safety of discharging using the Apollo app versus the routine process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
November 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 5, 2025
CompletedSeptember 19, 2024
August 1, 2024
8 months
August 11, 2024
September 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The mean time needed from discharge decision until the actual discharge
up to 24 hours from discharge decision
Secondary Outcomes (4)
Satisfaction rate from the discharge method
Within a week following discharge from the department
The rate of participants with any technical difficulties to receive the discharge letter and reasons
Within a week following discharge from the department using a questionnaire
The rate of participants with missed information that required the patient to seek medical help
Within a week following discharge from the department using a questionnaire
The rate of participants with discrepancies between the discharge recommendations written in the final discharge letter and the "Form for discharge and consent to receive a discharge letter, using application" and details regarding the discripancies
Within a week following discharge from the department
Study Arms (2)
Application discharge
EXPERIMENTALThe discharge is conditional on the approval of a senior physician or the attending physician in charge. The participant will sign on a "Form for discharge and consent to receive a discharge letter, using the "Apollo" application" in which the discharge process, recommendations and contact information of the department are described. Thereafter, the patient will be discharge home and the discharge letter will be available in the app once it is written. The participant is guided to contact the department, in case the discharge letter is not received in the application up to 24 hours after discharge.
Regular discharge
OTHERThe discharge is conditional on the approval of a senior physician or the attending physician in charge. The patient will go home only after the discharge letter is written.
Interventions
Eligibility Criteria
You may qualify if:
- Women who are admitted to the maternal and fetal medicine unit with the intention to be discharged before delivery
- years old and older
- Consent to participate
- Owner of a smart phone
- Consent to download the Apollo app
You may not qualify if:
- Delivery during her admission
- Doesn't own a smart phone
- Refusal to download to Apollo app
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tzafon Medical center, Poriya
Tiberias, North, 15208, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2024
First Posted
September 19, 2024
Study Start
November 30, 2024
Primary Completion
August 5, 2025
Study Completion
September 5, 2025
Last Updated
September 19, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share